BL M11D1 in patients with Relapsed/Refractory Acute Myeloid Leukemia

A Multicenter, Open-Label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of BL M11D1 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (BL-M11D1-HM-101)

Disease Types: Leukemia

Available at: Roanoke

A Multicenter, Open-Label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of BL M11D1 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (BL-M11D1-HM-101)

For More Information:

https://clinicaltrials.gov/study/NCT06714591?term=BL-M11D1-HM-101&rank=1